Related Experiment Videos
Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells
D K Armstrong1, S H Kaufmann, Y L Ottaviano
1Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.
Abstract:
MDA-MB-468 human breast cancer cells lack estrogen receptors, overexpress epidermal growth factor (EGF) receptors, and are growth inhibited by EGF. We show that treatment of MDA-MB-468 cells with EGF leads to inhibition of cell proliferation, fragmentation of DNA into nucleosomal oligomers, and the development of apoptotic morphology. This treatment is associated with increased expression of c-myc, c-fos, jun family members, and transforming growth factor beta 1 mRNA and with partial proteolytic cleavage of poly(ADP-ribose) polymerase and lamin B. The observation that EGF can mediate apoptosis in EGF receptor-overexpressing cells has important implications for clinical efforts directed at the EGF receptor.
Insights
Epidermal growth factor (EGF) triggers apoptosis in human breast cancer cells that overexpress EGF receptors. This finding is crucial for developing targeted therapies for EGF receptor-driven cancers.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- MDA-MB-468 cells are a human breast cancer cell line.
- These cells lack estrogen receptors but overexpress epidermal growth factor (EGF) receptors.
- Epidermal growth factor (EGF) inhibits the growth of these cells.
Purpose of the Study:
- To investigate the effects of EGF on MDA-MB-468 cells.
- To determine if EGF can induce apoptosis in these cells.
- To explore the molecular mechanisms underlying EGF-mediated apoptosis.
Main Methods:
- Treatment of MDA-MB-468 cells with EGF.
- Analysis of cell proliferation and DNA fragmentation.
- Assessment of apoptotic morphology.
- Measurement of gene expression (c-myc, c-fos, jun, TGF-beta 1).
- Evaluation of protein cleavage (PARP, lamin B).
Main Results:
- EGF treatment inhibited cell proliferation.
- DNA fragmentation into nucleosomal oligomers was observed.
- Apoptotic morphology developed in treated cells.
- Increased mRNA expression of c-myc, c-fos, jun, and transforming growth factor beta 1.
- Partial proteolytic cleavage of poly(ADP-ribose) polymerase and lamin B occurred.
Conclusions:
- EGF can induce apoptosis in human breast cancer cells overexpressing EGF receptors.
- The findings have significant implications for clinical strategies targeting the EGF receptor pathway.
- This study highlights a potential therapeutic mechanism for EGF receptor-overexpressing cancers.